1,174
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Cell-to-cell distances between tumor-infiltrating inflammatory cells have the potential to distinguish functionally active from suppressed inflammatory cells

, , , , , & show all
Article: e1127494 | Received 07 Oct 2015, Accepted 25 Nov 2015, Published online: 29 Apr 2016

References

  • Galon J, Angell HK, Bedognetti D, Marincola FM. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures. Immunity 2013; 39:11-26; PMID:23890060; http://dx.doi.org/10.1016/j.immuni.2013.07.008
  • Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004; 21:137-48; PMID:15308095; http://dx.doi.org/10.1016/j.immuni.2004.07.017
  • Yu P, Fu YX. Tumor-infiltrating T lymphocytes: friends or foes? Lab Invest 2006; 86:231-45; PMID:16446705; http://dx.doi.org/10.1038/labinvest.3700389
  • Galon J, Mlecnik B, Bindea G, Angell HK, Berger A, Lagorce C, Lugli A, Zlobec I, Hartmann A, Bifulco C et al. Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol 2014; 232:199-209; PMID:24122236; http://dx.doi.org/10.1002/path.4287
  • Piccirillo CA, Thornton AM. Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells. Trends Immunol 2004; 25:374-80; PMID:15207505; http://dx.doi.org/10.1016/j.it.2004.04.009
  • Zhang X, Kelaria S, Kerstetter J, Wang J. The functional and prognostic implications of regulatory T cells in colorectal carcinoma. J Gastrointestinal Oncol 2015; 6:307-13; PMID:26029458; http://dx.doi.org/10.3978/j.issn.2078-6891.2015.017.
  • Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10:490-500; PMID:20559327; http://dx.doi.org/10.1038/nri2785
  • Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22:329-60; PMID:15032581; http://dx.doi.org/10.1146/annurev.immunol.22.012703.104803
  • Wang Q, Feng M, Yu T, Liu X, Zhang P. Intratumoral regulatory T cells are associated with suppression of colorectal carcinoma metastasis after resection through overcoming IL-17 producing T cells. Cell Immunol 2014; 287:100-5; PMID:24487033; http://dx.doi.org/10.1016/j.cellimm.2014.01.002
  • Askenasy N, Kaminitz A, Yarkoni S. Mechanisms of T regulatory cell function. Auto Immunity Rev 2008; 7:370-5; PMID:25599534; http://dx.doi.org/10.1016/j.autrev.2008.03.001
  • Heindl A, Nawaz S, Yuan Y. Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology. Lab Invest 2015; 95:377-84; PMID:25599534; http://dx.doi.org/10.1038/labinvest.2014.155
  • Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 2013; 39:782-95; PMID:24138885; http://dx.doi.org/10.1016/j.immuni.2013.10.003
  • Grabenbauer GG, Kessler H, Matzel KE, Sauer R, Hohenberger W, Schneider IH. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients. Dis Colon Rectum 2005; 48:1742-51; PMID:15991058; http://dx.doi.org/10.1007/s10350-005-0098-5
  • Grabenbauer GG, Lahmer G, Distel L, Niedobitek G. Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma. Clin Cancer Res 2006; 12:3355-60; PMID:16740757; http://dx.doi.org/10.1158/1078-0432.CCR-05-2434
  • Haas M, Dimmler A, Hohenberger W, Grabenbauer GG, Niedobitek G, Distel LV. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. BMC Gastroenterol 2009; 9:65; PMID:19732435; http://dx.doi.org/10.1186/1471-230X-9-65
  • Feichtenbeiner A, Haas M, Buttner M, Grabenbauer GG, Fietkau R, Distel LV. Critical role of spatial interaction between CD8(+) and Foxp3(+) cells in human gastric cancer: the distance matters. Cancer Immunol Immunother 2014; 63:111-9; PMID:24170095; http://dx.doi.org/10.1007/s00262-013-1491-x
  • Rave-Frank M, Tehrany N, Kitz J, Leu M, Weber HE, Burfeind P, Schliephake H, Canis M, Beissbarth T, Reichardt HM et al. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma. Strahlenther Onkol 2016; 192:47-54; PMID:26374452; http://dx.doi.org/10.1007/s00066-015-0892-5
  • Tehrany N, Kitz J, Rave-Frank M, Lorenzen S, Li L, Kuffer S, Hess CF, Burfeind P, Reichardt HM, Canis M et al. High-grade acute organ toxicity and p16(INK4A) expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma. Strahlenther Onkol 2015; 191:566-72; PMID:25575976; http://dx.doi.org/10.1007/s00066-014-0801-3
  • Distel L, Fickenscher R, Dietel K, Hung A, Iro H, Zenk J, Nkenke E, Büttner M, Niedobitek G, Grabenbauer G. Tumour infiltrating lymphocytes in squamous cell carcinoma of the oro-and hypopharynx: Prognostic impact may depend on type of treatment and stage of disease. Oral Oncol 2009; 45(10):e167-74; PMID:19576838; http://dx.doi.org/10.1016/j.oraloncology.2009.05.640
  • Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81; http://dx.doi.org/10.1080/01621459.1958.10501452
  • Bland JM, Altman DG. The logrank test. BMJ 2004; 328:1073; PMID:15117797; http://dx.doi.org/10.1136/bmj.328.7447.1073

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.